WHO
The silent killer: why chronic respiratory disease deserves global attention
Multisectoral Action
25 Nov 2024
News
WHO and St. Jude to dramatically increase global access to childhood cancer medicines
World Health Organization | 13 Dec 2021
Biggest ever financial commitment to childhood cancer medicines in low- and middle-income countries
The World Health Organization and St. Jude Children’s Research Hospital today announced plans to establish a platform that will dramatically increase access to childhood cancer medicines around the world.
The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. St. Jude is making a six-year, US$ 200 million investment to launch the platform, which will provide medicines at no cost to countries participating in the pilot phase. This is the largest financial commitment for a global effort in childhood cancer medicines to date.
